1
|
Matsuoka K, Taoka M, Satozawa N, et al: A
nuclear factor containing the leucine-rich repeats expressed in
murine cerebellar neurons. Proc Natl Acad Sci USA. 91:9670–9674.
1994. View Article : Google Scholar : PubMed/NCBI
|
2
|
Chen TH, Brody JR, Romantsev FE, et al:
Structure of pp32, an acidic nuclear protein which inhibits
oncogene-induced formation of transformed foci. Mol Biol Cell.
12:2045–2056. 1996. View Article : Google Scholar : PubMed/NCBI
|
3
|
Kadkol SS, Brody JR, Pevsner J, Bai J and
Pasternack GR: Modulation of oncogenic potential by alternative
gene use in human prostate cancer. Nat Med. 5:275–279. 1999.
View Article : Google Scholar
|
4
|
Kadkol SS, El Naga GA, Brody JR, et al:
Expression of pp32 gene family members in breast cancer. Breast
Cancer Res Treat. 68:65–73. 2001. View Article : Google Scholar : PubMed/NCBI
|
5
|
Pan W, da Graca LS, Shao Y, Yin Q, Wu H
and Jiang X: PHAPI/pp32 suppresses tumorigenesis by stimulating
apoptosis. J Biol Chem. 284:6946–6954. 2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Adegbola O and Pasternack G:
Phosphorylated retinoblastoma protein complexes with pp32 and
inhibits pp32-mediated apoptosis. J Biol Chem. 280:15497–15502.
2005. View Article : Google Scholar : PubMed/NCBI
|
7
|
Matilla A, Koshy BT, Cummings CJ, Isobe T,
Orr HT and Zoghbi HY: The cerebellar leucine-rich acidic nuclear
protein interacts with ataxin-1. Nature. 389:974–978. 1997.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Beresford PJ, Kam CM, Powers JC and
Lieberman J: Recombinant human granzyme A binds to two putative
HLA-associated proteins and cleaves one of them. Proc Natl Acad Sci
USA. 94:9285–9290. 1997. View Article : Google Scholar : PubMed/NCBI
|
9
|
Brennan CM, Gallouzi IE and Steitz JA:
Protein ligands to HuR modulate its interaction with target mRNA
in vivo. J Cell Biol. 151:1–14. 2000. View Article : Google Scholar : PubMed/NCBI
|
10
|
Gallouzi IE, Brennan CM and Steitz JA:
Protein ligands mediate the CRM1-dependent export of HuR in
response to heat shock. RNA. 7:1348–1361. 2001. View Article : Google Scholar
|
11
|
Ma WJ, Cheng S, Campbell C, Wright A and
Furneaux H: Cloning and characterization of HuR, a ubiquitously
expressed Elav-like protein. J Biol Chem. 99:8144–8151.
1996.PubMed/NCBI
|
12
|
Hinman MN and Lou H: Diverse molecular
functions of Hu proteins. Cell Mol Life Sci. 65:3168–3181. 2008.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Lopez de Silanes I, Lal A and Gorospe M:
HuR: post-transcriptional paths to malignancy. RNA Biol. 2:11–13.
2005.PubMed/NCBI
|
14
|
López de Silanes I, Fan J, Yang X, et al:
Role of the RNA-binding protein HuR in colon carcinogenesis.
Oncogene. 22:7146–7154. 2003.PubMed/NCBI
|
15
|
Srikantan S and Gorospe M: HuR function in
disease. Front Biosci. 17:189–205. 2012. View Article : Google Scholar
|
16
|
Higashino F, Aoyagi M, Takahashi A, et al:
Adenovirus E4orf6 targets pp32/LANP to control the fate of
ARE-containing mRNA by perturbing the CRM1-dependent mechanism. J
Cell Biol. 170:15–20. 2005. View Article : Google Scholar : PubMed/NCBI
|
17
|
Kuroshima T, Aoyagi M, Yasuda M, et al:
Viral-mediated stabilization of AU-rich element containing mRNA
contributes to cell transformation. Oncogene. 30:2912–2920. 2011.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Hasegawa H, Kakuguchi W, Kuroshima T, et
al: HuR is exported to the cytoplasm in oral cancer cells in a
different manner from that of normal cells. Br J Cancer.
100:1943–1948. 2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Kakuguchi W, Kitamura T, Kuroshima T, et
al: HuR knockdown changes the oncogenic potential of oral cancer
cells. Mol Cancer Res. 8:520–528. 2010. View Article : Google Scholar : PubMed/NCBI
|
20
|
Mazroui R, Di Marco S, Clair E, et al:
Caspase-mediated cleavage of HuR in the cytoplasm contributes to
pp32/PHAP-I regulation of apoptosis. J Cell Biol. 180:113–127.
2008. View Article : Google Scholar : PubMed/NCBI
|
21
|
Weigel S and Dobbelstein M: The nuclear
export signal within the E4orf6 protein of adenovirus type 5
supports virus replication and cytoplasmic accumulation of viral
mRNA. J Virol. 74:764–772. 2000. View Article : Google Scholar : PubMed/NCBI
|
22
|
Aoyagi M, Higashino F, Yasuda M, et al:
Nuclear export of the adenovirus E4orf6 protein is necessary for
its ability to antagonize the apoptotic activity of the BH3-only
proteins. Oncogene. 22:6919–6927. 2003. View Article : Google Scholar : PubMed/NCBI
|
23
|
Higashino F, Pipas JM and Shenk T:
Adenovirus E4orf6 oncoprotein modulates the function of the
p53-related protein, p73. Proc Natl Acad Sci USA. 95:15683–15687.
1998. View Article : Google Scholar : PubMed/NCBI
|
24
|
Buddaseth S, Göttmann W, Blasczyk R, et
al: Dysregulation of cell cycle caused by overexpression of the
oncogene pp32r1 (ANP32C) and the Tyr>His mutant pp32r1Y140H.
Biochim Biophys Acta. 1833:1212–1221. 2013. View Article : Google Scholar : PubMed/NCBI
|